Cerebrovascular Diseases
Original Paper
Long-Term Prognosis, by Stroke Subtypes, after a First-Ever Stroke: A Hospital-Based Study over a 20-Year PeriodYokota C.a,b · Minematsu K.b · Hasegawa Y.b · Yamaguchi T.baCerebrovascular Laboratory, National Cardiovascular Center Research Institute, and bCerebrovascular Division, Department of Medicine, National Cardiovascular Center, Osaka, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 02, 2003
Accepted: January 14, 2004
Published online: August 05, 2004
Issue release date: August 2004
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Abstract
Background and Purpose: The influence of stroke subtype on recurrence, and determinants of recurrence-free survival after a first-ever stroke are not fully understood. We aimed to clarify the long-term prognosis by stroke subtypes and to identify determinants for recurrence and death after a first-ever stroke. Methods: We enrolled 1,732 consecutive patients (men/women = 1,134/598, mean age of 65 years) with a first-ever acute stroke who were admitted to our Stroke Care Unit during a period of 20 years. Stroke subtypes were classified as atherothrombotic brain infarction, lacunar infarction, cardioembolic infarction, other type of infarction, and brain hemorrhage. The prognosis was assessed by stroke subtypes. Results: During the hospital stay (mean 61 days), 99 patients died: 73 died directly from stroke. A total of 198 patients had recurrent strokes, and 286 died within 3 years after the index stroke. The overall recurrence rate within the first year was 6.5%, which was different among stroke subtypes. Patients with cardioembolic infarction (9.0%) as well as other type of infarction (9.1%) had more recurrent strokes within the initial year compared with the other subtypes. A history of transient ischemic attack (relative risk = 1.38), atrial fibrillation (1.52), ischemic heart disease (1.40), and disability at discharge (2.64) were independent predictors for the recurrence and death within 3 years after the first-ever stroke. Conclusions: The recurrence rate was different among stroke subtypes within 1 year after the index stroke. Atrial fibrillation, ischemic heart disease, history of transient ischemic attack, and disability at discharge were important determinants for stroke recurrence and death.
© 2004 S. Karger AG, Basel
Related Articles:
References
- Liu L, Ikeda K, Yamori Y: Changes in stroke mortality rates for 1950 to 1997: A great slowdown of decline trend in Japan. Stroke 2001;32:1745–1749.
- National Institute of Neurological Disorders and Stroke Ad Hoc Committee: Classification of Cerebrovascular Diseases III. Stroke 1990;21:637–676.
- Fisher CM: Lacuner strokes and infarcts: A review. Neurology 1982;32:871–876.
- Minematsu K, Yamaguchi T, Omae T: ‘Spectacular shrinking deficit’: Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157–162.
-
UK-TIA Study Group: The UK-TIA aspirin trial: Interim results. Br Med J 1988;296:316–320.
External Resources
- Evans A, Harraf F, Donaldson N, Kalra L: Randomized controlled study of stroke unit care versus stroke team care in different stroke subtypes. Stroke 2002;33:449–455.
- Kalra L, Evans A, Perez I, Knapp M, Donaldson N, Swift CG: Alternative strategies for stroke care: A prospective randomised controlled trial. Lancet 2000;356:894–899.
- Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG: Long-term risk of first recurrent stroke in the Perth community stroke study. Stroke 1998;29:2491–2500.
- Bogousslavsky J, Melle GV, Regli F: The Lausanne stroke registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.
- Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener H-C, on behalf of the German Stroke Data Bank Collaborators: Risk factors, outcome, and treatment in subtypes of ischemic stroke: German stroke data bank. Stroke 2001;32:2559–2566.
- Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke 2001;32:2735–2740.
- Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC: Subtypes of ischemic stroke: A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997;28:2507–2512.
- Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke 2000;31:2616–2622.
- Yoneda Y, Uehara T, Yamasaki H, Kita Y, Tabuchi N, Mori E: Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 2003;34:718–724.
- Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO: Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke 2000;31:1062–1068.
- Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJE: Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002;59:205–209.
- Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CDA: Cause of stroke recurrence is multifactorial: Patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003;34:1457–1463.
- Anderson C, Rubenach S, Mhurchu CN, Clark M, Spencer C, Winsor A: Home or hospital for stroke rehabilitation? Results of a randomized controlled trial. 1. Health outcomes at 6 months. Stroke 2000;31:1024–1031.
-
Joergensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS: Acute stroke with atrial fibrillation: The Copenhagen stroke study. Stroke 1996;10:1765–1769.
Article / Publication Details
Received: June 02, 2003
Accepted: January 14, 2004
Published online: August 05, 2004
Issue release date: August 2004
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
